
Join to view full profile
20 Chambers Dr# ElliotHooksett, NH 03106
Phone+1 603-624-8652
Fax+1 603-624-6609
Dr. Kehas is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Concord Hospital/New Hampshire-Dartmouth Family MedicineResidency, Family Medicine, 2003 - 2006
Tufts University School of MedicineClass of 2003
Certifications & Licensure
NH State Medical License 2006 - 2028
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
Publications & Presentations
PubMed
- 38 citationsTranscriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cellsJosé A. Teixeira, David J. Kehas, Reem Antun, Patricia K. Donahoe
Proceedings of the National Academy of Sciences of the United States of America. 1999-11-23 - 103 citationsHuman ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISPeter T. Masiakos, David T. MacLaughlin, Shyamala Maheswaran, José A. Teixeira, Arlan F. Fuller
Clinical Cancer Research. 1999-11-01 - 59 citationsDiagnostic Utility of Müllerian Inhibiting Substance Determination in Patients with Primary and Recurrent Granulosa Cell TumorsAndrew H. Lane, Mary M. Lee, Arlan F. Fuller, David J. Kehas, Patricia K. Donahoe
Gynecologic Oncology. 1999-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









